Last Updated: November 5, 2026

Litigation Details for AMGEN INC v. SANDOZ INC. (D.N.J. 2018)

✉ Email this page to a colleague

« Back to Dashboard

AMGEN INC v. SANDOZ INC. (D.N.J. 2018)

Docket	⤷ Start Trial	Date Filed	2018-06-26
Court	District Court, D. New Jersey	Date Terminated	2021-09-28
Cause	15:1126 Patent Infringement	Assigned To	Michael Andre Shipp
Jury Demand	None	Referred To	Douglas Arpert
Parties	CELGENE CORPORATION; SANDOZ INC.
Patents	10,092,541; 6,962,940; 7,208,516; 7,427,638; 7,659,302; 7,893,101; 8,455,536; 8,802,717; 9,018,243; 9,724,330; 9,872,854
Attorneys	AUROBINDO PHARMA LIMITED; STEPHEN M. KLEIN
Firms	Benesch Friedlander Coplan & Aronoff LLP; Yevgenia Shtilman Kleiner
Link to Docket	External link to docket

Small Molecule Drugs cited in AMGEN INC v. SANDOZ INC.

The small molecule drugs covered by the patents cited in this case are ⤷ Start Trial and ⤷ Start Trial .

Details for AMGEN INC v. SANDOZ INC. (D.N.J. 2018)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2018-06-26				External link to document
2018-06-26	1	Complaint	United States Patent Nos. 6,962,940 (“the ’940 Patent”), 7,208,516 (“the ’516 Patent”), 7,427,638 (“… U.S. Patent Nov. 8, 2005 Sheet 1 of 2 US 6,962,940 B2 …PageID: 71 U.S. Patent Nov. 8, 2005 Sheet 2 of 2 US 6,962,940 B2 … US 6,962,940 B2 Muller et al. (45) Date… US 6,962,940 B2	External link to document
2018-06-26	355	In Limine	Infringement Opinions of Dr. Alexis Regarding U.S. Patent No. 10,092,541 by ALKEM LABORATORIES LTD.. (CAPUZZI, KEVIN… 28 September 2021 3:18-cv-11026 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2018-06-26	356	Brief	Infringement Opinions of Dr. Alexis Regarding U.S. Patent No. 10,092,541 (CAPUZZI, KEVIN)NOTICE TO COUNSEL: Counsel… 28 September 2021 3:18-cv-11026 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2018-06-26	357	Declaration	Infringement Opinions of Dr. Alexis Regarding U.S. Patent No. 10,092,541, 356 Brief,, by ALKEM LABORATORIES LTD..… 28 September 2021 3:18-cv-11026 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2018-06-26	370	Notice (Other)	(“the ‘536 Patent”), 8,093,283 (“the ‘283 Patent), and 10,092,541 (“the ‘541 Patent”). Defendants…of U.S. Patent No. 9,872,854  Patent Prosecution History of U.S. Patent No. 10,092,541 …  U.S. Patent No. 10,092,541 (Issued Oct. 9, 2018 to Day, et al.)  U.S. Patent No. 6,962,…regarding U.S. Patent Nos. 7,427,638 (“the ‘638 Patent”), 7,893,101 (“the ‘101 Patent”), 8,455,536 (… the ‘536 Patent, claims 1 and 15 of the ‘101 Patent, claims 2 and 27 of the ‘283 Patent, and claims	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.